Iovance Biotherapeutics (IOVA) Gross Margin (2023 - 2026)
Iovance Biotherapeutics (IOVA) posted Gross Margin of 56.10% for Q2 2026, up 37.64 percentage points from 18.47% a year earlier and up 15.60 percentage points from the prior quarter.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) Gross Margin (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Margin at Iovance Biotherapeutics was 48.40%, up 15.02 percentage points year-over-year; for FY2025, it came in at 34.28%, down 8.89 percentage points from FY2024.
- In prior years, Iovance Biotherapeutics' Gross Margin was 43.17% in FY2024 (+30.05 pp) and 13.12% in FY2023.
- The Q2 2026 figure stands as the highest quarterly Gross Margin since Q4 2023.
- On a year-over-year basis, Gross Margin has increased in each of the last three quarters, with an average year-over-year change of +90.03 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Gross Margin in the past five years was Q1 2025, with a gain of 928.92 percentage points; the weakest was Q4 2024, with a drop of 1162.69 percentage points.
- According to Business Quant data, Gross Margin for the three prior quarters was 40.50% (Q1 2026), 50.32% (Q4 2025) and 42.96% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Iovance Biotherapeutics | 4.98 Bn | 3.77 Bn | 55.72 Mn | 56.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 56.10% |
| Mar 31, 2026 | 40.50% |
| Dec 31, 2025 | 50.32% |
| Sep 30, 2025 | 42.96% |
| Jun 30, 2025 | 18.47% |
| Mar 31, 2025 | 13.40% |
| Dec 31, 2024 | 48.72% |
| Sep 30, 2024 | 46.17% |
| Jun 30, 2024 | -0.84% |
| Mar 31, 2024 | -915.52% |
| Dec 31, 2023 | 1,211.41% |
| Sep 30, 2023 | -825.37% |
| Jun 30, 2023 | -761.34% |
API Access
Iovance Biotherapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=IOVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();